Horm Metab Res 2024; 56(03): 235-243
DOI: 10.1055/a-2246-4778
Original Article: Endocrine Research

ETV5 Silencing Produces Mesenchymal to Epithelial Transition in INS-1 (832/13) Cell Line

Yael Efrén Díaz-López
1   División de Investigación, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City, Mexico
2   Laboratorio de Investigación en Enfermedades Metabólicas, Obesidad y Diabetes, Hospital Infantil de México Federico Gomez, Mexico City, Mexico
,
Vicenta Cázares-Domínguez
2   Laboratorio de Investigación en Enfermedades Metabólicas, Obesidad y Diabetes, Hospital Infantil de México Federico Gomez, Mexico City, Mexico
,
Francisco Arenas-Huertero
3   Laboratorio de Investigación en Patología Experimental, Hospital Infantil de México Federico Gómez, Mexico City, Mexico
,
Ruth Gutierrez-Aguilar
1   División de Investigación, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City, Mexico
2   Laboratorio de Investigación en Enfermedades Metabólicas, Obesidad y Diabetes, Hospital Infantil de México Federico Gomez, Mexico City, Mexico
› Author Affiliations

Funding Information Consejo Nacional de Ciencia y Tecnología (CONACYT) — Postgraduate student “Ciencias Bioquímicas” Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México — http://dx.doi.org/10.13039/501100006087; PAPIIT IA200116 Hospital Infantil de México Federico Gómez — HIM2014/056 SSA 1132
Preview

Abstract

ETV5 has been described to be involved in the epithelial to mesenchymal transition (EMT) mainly in cancer. It is known that EMT provokes cytoskeleton remodeling, improving cellular migratory, and invasive capabilities. Moreover, overexpression of ETV5 has been correlated to cancer development and this gene has been implicated in cell proliferation. However, little is known about the downregulation of ETV5 expression in a pancreatic cell line and the inverse mesenchymal to epithelial transition (MET). Therefore, we studied the implications of ETV5 silencing over the phenotype of the insulinoma INS-1 (832/13) cell line and described the MET by partial ETV5 silencing in the INS-1 (832/13) cell line. The downregulation of ETV5 expression was obtained by using ETV5 siRNA in the insulinoma rat cell line, INS-1 (832/13). Then, ETV5 knockdown provoked a MET phenotype observed by crystal violet staining and verified by immunohistochemistry against E-cadherin. Wound healing assay showed no migration, and F-actin stain revealed rearrangement of actin microfilaments. In addition, TGFβ1 and TGFβ3 were downregulated in the absence of ETV5. ETV5 silencing induces epithelial phenotype by downregulating TGFβ1 and TGFβ3 in INS-1 (832/13) cell line.



Publication History

Received: 08 August 2022

Accepted after revision: 11 January 2024

Article published online:
09 February 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag
Rüdigerstraße 14, 70469 Stuttgart, Germany